sábado, 12 de octubre de 2024

FDA Approves New Treatment for Hemophilia A or B Product is First Non-Factor and Once-Weekly Treatment for Hemophilia B

https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-hemophilia-or-b?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario